TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Novavax AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
551,005
|
1,049,786
|
713,237 |
Financial expenses |
456,816
|
516,058
|
311,832 |
Earnings before taxes |
130,909
|
346,270
|
-81,122 |
EBITDA |
150,301
|
358,837
|
-73,072 |
Total assets |
2,428,598
|
2,504,411
|
2,613,100 |
Current assets |
138,038
|
1,762,418
|
1,867,729 |
Current liabilities |
885,900
|
1,110,047
|
1,512,674 |
Equity capital |
1,542,699
|
1,394,364
|
1,100,426 |
- share capital |
34
|
33
|
36 |
Employees (average) |
195
|
167
|
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.5%
|
55.7%
|
42.1% |
Turnover per employee |
2,826
|
6,286 | |
Profit as a percentage of turnover |
23.8%
|
33.0%
|
-11.4% |
Return on assets (ROA) |
24.2%
|
34.4%
|
8.8% |
Current ratio |
15.6%
|
158.8%
|
123.5% |
Return on equity (ROE) |
8.5%
|
24.8%
|
-7.4% |
Change turnover |
-504,186
|
394,322
|
425,892 |
Change turnover % |
-48%
|
60%
|
148% |
Chg. No. of employees |
28
|
167
|
-57 |
Chg. No. of employees % | 17% | -100% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.